All About Gluten & Celiac Disease
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Historial Perspectives in Translational Medicine
Historial Perspectives in Translational Medicine Willem Dicke. Brilliant Clinical Observer and Translational Investigator. Discoverer of the Toxic Cause of Celiac Disease David Yan 1 and Peter R. Holt , M.D. 2 Abstract We can admire and learn from physicians with acute clinical acumen and superb approaches to translational research. The observations and studies of Dr. Willem Dicke, a Dutch pediatrician, on the toxic effects of a protein component of wheat and rye demonstrate the highest quality of such investigations. From a clinical observation of one child with celiac disease, through years of historical questioning and empirical dietary suggestions of patient families, he concluded that such foods were toxic. When research became possible after the second world war and fecal fat measures as a hard end point became available he studied 5 children in detail to establish the validity of his clinical clues. Keywords: celiac disease , translational research , diet Progress in defining clinical disorders often requires the One dietary approach was to reduce or eliminate dietary fat combination of careful observations of the patient’s disease, since the stools of patients had a greatly increased fat content. intuition and the ability to perform the clinical translational However, such diets were calorically severely defi cient. Other research to prove a hypothesis. Th e story of William Dicke, a clinical observation stimulated the conclusion that carbohydrate Dutch pediatrician, who had the birth of an idea from a case ingestion increased the weight and water contents of the stools.6 report from listening to his child patients’ mothers, who then Improvement in patients was noted when carbohydrates, including continued clinical questioning of families with children with wheat products, were omitted from the diet; 7 however, clinicians the disease for almost a decade and then wrote his thesis on a also reduced ingested fat to lower fecal fat content, a calorically remarkably careful series of clinical studies which resulted in insuffi cient diet. -
Celiac Disease Gluten Wheat Allergy
Celiac Disease vs. Gluten Intolerance vs. Wheat Allergies Are you confused by the different terms for certain food allergies? You are not alone. These terms are sometimes interchanged while describing each other which adds to the confusion. Celiac disease, wheat allergy, and gluten-intolerance while treated similarly, are not the same conditions. Consequently, it is very important for a person to know which condition they have. Your family health care provider can help you evaluate and diagnose your specific condition. What Is Celiac Disease? Celiac disease is an auto-immune disease, which means your body starts attacking itself and its organs. It is usually triggered by an exposure to gluten but only if you are genetically programmed to have celiac disease. For example, many undiagnosed cases have led to people getting their gall bladders and spleens removed because the doctor thought those organs were malfunctioning, when in reality, they were being attacked. Celiac disease also puts the patient at risk for developing other autoimmune conditions such as thyroid disease, type 1 diabetes and liver diseases. The good news is, it is the only auto-immune disease with a cure. The only known cure? A drastic dietary change which means you must avoid all gluten at all times. What is Gluten? Gluten is a special type of protein found commonly in rye, wheat, and barley. It is found in most all types of cereals and in many types of bread. Some examples of grains that do NOT have gluten include wild rice, corn, buckwheat, millet, oats, soybeans and quinoa. What is Gluten Intolerance ? Gluten intolerance is not an autoimmune disease and can happen to anyone, especially if you already have allergies. -
Celiac Disease: It's Autoimmune Not an Allergy
CELIAC DISEASE: IT’S AUTOIMMUNE NOT AN ALLERGY! Analissa Drummond PA-C Department of Pediatrics Division of Pediatric Gastroenterology HISTORY OF CELIAC DISEASE Also called gluten-sensitive enteropathy and nontropical spue First described by Dr. Samuel Gee in a 1888 report entitled “On the Coeliac Affection” Term “coeliac” derived from Greek word koiliakaos-abdominal Similar description of a chronic, malabsorptive disorder by Aretaeus from Cappadochia ( now Turkey) reaches as far back as the second century AD HISTORY CONTINUED The cause of celiac disease was unexplained until 1950 when the Dutch pediatrician Willem K Dicke recognized an association between the consumption of bread, cereals and relapsing diarrhea. This observation was corroborated when, during periods of food shortage in the Second World War, the symptoms of patients improved once bread was replaced by unconventional, non cereal containing foods. This finding confirmed the usefulness of earlier empirical diets that used pure fruit, potatoes, banana, milk, or meat. HISTORY CONTINUED After the war bread was reintroduced. Dicke and Van de Kamer began controlled experiments by exposing children with celiac disease to defined diets. They then determined fecal weight and fecal fat as a measure of malabsorption. They found that wheat, rye, barley and to a lesser degree oats, triggered malabsorption, which could be reversed after exclusion of the “toxic” cereals from the diet. Shortly after, the toxic agents were found to be present in gluten, the alcohol-soluble fraction of wheat protein. PATHOPHYSIOLOGY Celiac disease is a multifactorial, autoimmune disorder that occurs in genetically susceptible individuals. Trigger is an environmental agent-gliadin component of gluten. -
Protein Fractions of Oats and Possibilities of Oat Utilisation for Patients with Coeliac Disease
Czech J. Food Sci. Vol. 22, No. 4: 151–162 Protein Fractions of Oats and Possibilities of Oat Utilisation for Patients with Coeliac Disease I���� CAPOUCHOVÁ1, J��� PETR1, H����� TLASKALOVÁ-HOGENOVÁ2, I��� MICHALÍK3, O������ FAMĚRA1, D��� URMINSKÁ3, L������ TUČKOVÁ2, H������� KNOBLOCHOVÁ3 and D��� BOROVSKÁ2 1Czech University of Agriculture in Prague, Prague, Czech Republic; 2Microbiological Institute of the Academy of Sciences of the Czech Republic, Prague, Czech Republic; 3Slovak University of Agriculture, Nitra, Slovak Republic Abstract C��������� I., P��� J., T���������-H������� H., M������� I., F����� O., U������� D., T������ L., K���������� H., B������� D. (2004): Protein fractions of oats and possibilities of oat utilisation for patients with coeliac disease. Czech J. Food Sci., 22: 151–162. The applicability was evaluated of 16 different oats species and varieties of different provenance in the coeliac diet in view of the composition of the protein complex and immunological testing during two-year experiments (2001 and 2002). Determination was carried out of total nitrogen content (average of evaluated oats collection in 2001 was 2.21%, in 2002 2.78%), protein nitrogen content (average 2001 1.94%, 2002 2.28%), and crude protein (N × 6.25) content (average 2001 13.80%, 2002 17.37%). The proportions of different protein fractions play a decisive role for the aims of this study because, based on the existing knowledge, coeliacally active protein components are present particularly in the prolamin fraction. The percentage of prolamins (determined by discontinual fractionation after Osborne) in the author’s evaluated collection of oats species and varieties under the conditions of Central Bohemia reached on average 17.68% of the total protein in 2001, and 15.36% in 2002. -
Baker's Asthma, Food and Wheat Pollen Allergy
C HAPTER 14 Wheat as an Allergen: Baker’s Asthma, Food and Wheat Pollen Allergy Alicia Armentia1, Eduardo Arranz2, José Antonio Garrote2,3, Javier Santos4 1 Allergy Unit. io !ortega University !os"ital. #alladolid. S"ain. 2 $BG&. University o' #alladolid(CS$C. #alladolid. S"ain. 3 Clinical *a+oratory ,epartment. io !ortega University !os"ital. #alladolid. S"ain. 4 Gastroenterology ,epartment. io !ortega University !os"ital. #alladolid. S"ain. aliciaarmentia-gmail.com, [email protected], [email protected], .aviersantos _ //-0otmail.com ,oi1 0tt"122dx.doi.org214.35262oms.262 How to !te th!s ha"ter Armentia A, Arranz E, Garrote JA, Santos J. Wheat as an Allergen: Baker’s Asthma, Food and Wheat Pollen Allergy. In Arranz E, Fernández-Bañares F, Rosell CM, Rodrigo L, eña AS, editors. Advances in the Understanding of Gluten elated Pathology and the Evolution of Gluten"Free Foods. Barcelona, Spain: OmniaScience; 2'(). p. 4+,-4--. 463 A. Armentia, E. Arranz, J.A. Garrote, J. Santos A # s t r a t 7ood incom"ati+ilities affect a""ro3imately 248 o' t0e "o"ulation and can +e caused +y allergy. &any "lant "roteins act as sensitizing agents in 0umans u"on re"eated ex"osure. 90eat is a "rominent allergen source and is one o' t0e causes o' +a:er;s ast0ma, food and "ollen allergy. <n t0e +asis o' differential solu+ility, =0eat grain "roteins 0ave +een classified as salt(solu+le al+umins and gluten fraction or "rolamins, =0ic0 include gliadins and glutenins. %ot0 "roteins sources 0ave +een im"licated in t0e develo"ment o' =0eat 0y"ersensitivity. -
Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low- Fodmaps Diet Trial
Arch Clin Biomed Res 2020; 4 (1): 017-032 DOI: 10.26502/acbr.50170086 Research Article Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low- FODMAPs diet Trial Riezzo Giuseppe1, Orlando Antonella1, Tutino Valeria2, Clemente Caterina1, Linsalata Michele1, Prospero Laura1, D’Attoma Benedetta1, Martulli Manuela1, Russo Francesco1* 1Laboratory of Nutritional Pathophysiology, National Institute of Gastroenterology “S. de Bellis” Research Hospital, IRCCS “Saverio de Bellis” Castellana Grotte (BA), Italy 2Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology “S. de Bellis” Research Hospital, IRCCS “Saverio de Bellis” Castellana Grotte (BA), Italy *Corresponding author: Dr. Francesco Russo, Laboratory of Nutritional Pathophysiology, National Institute of Gastroenterology “S. de Bellis” Research Hospital, IRCCS “Saverio de Bellis” Castellana Grotte (BA), Italy, Tel: +390804994129; Fax +390804994313; E-mail [email protected] Received: 14 January 2020; Accepted: 23 January 2020; Published: 03 February 2020 Citation: Riezzo Giuseppe, Orlando Antonella, Tutino Valeria, Clemente Caterina, Linsalata Michele, Prospero Laura, D’Attoma Benedetta, Martulli Manuela, Russo Francesco. Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low-FODMAPs diet Trial. Archives of Clinical and Biomedical Research 4 (2020): 017-031. Abstract diet improves symptoms is still an unsolved matter. On The intake of fermentable oligosaccharides, this basis, the study aimed to evaluate variations in the disaccharides, monosaccharides, and polyols circulating levels of molecules involved in the epithelial (FODMAPs) is linked to IBS symptoms. Thus, reduced barrier integrity and function following a low FODMAPs content in the diet may improve symptoms FODMAPs diet to find new diagnostic markers of IBS. -
Knowledge and Perceptions of a Gluten-Free Diet: a Mixed-Methods Approach
Knowledge and Perceptions of a Gluten-Free Diet: A Mixed-Methods Approach A thesis presented to the faculty of the College of Health Sciences and Professions of Ohio University In partial fulfillment of the requirements for the degree Master of Science Hannah E. Johnson August 2017 © 2017 Hannah E. Johnson. All Rights Reserved. 2 This thesis titled Knowledge and Perceptions of a Gluten-Free Diet: A Mixed-Methods Approach by HANNAH E. JOHNSON has been approved for the School of Applied Health Sciences and Wellness and the College of Health Sciences and Professions by Robert G. Brannan Associate Professor of Food and Nutrition Sciences Randy Leite Dean, College of Health Sciences and Professions 3 Abstract JOHNSON, HANNAH E., M.S., August 2017, Food and Nutrition Sciences Knowledge and Perceptions of a Gluten-Free Diet: A Mixed-Methods Approach Director of Thesis: Robert G. Brannan The practice of gluten-free diets is on the rise, yet many people are still unaware of what gluten is and how it functions in food. It is important that food and nutrition professionals are knowledgeable on this topic due to the prevalence of gluten-related disorders and the popularity of gluten-free as a fad diet. The purpose of this research was to use a mixed methods approach using qualitative and quantitative methods to obtain and evaluate knowledge and perceptions of a gluten-free diet from future and current food and nutrition professionals. In the first phase of the research, a laboratory questionnaire was administered to assess students enrolled in the Food Science course on their knowledge of gluten. -
Gut Microbiota Differs in Composition and Functionality Between Children
Diabetes Care Volume 41, November 2018 2385 Gut Microbiota Differs in Isabel Leiva-Gea,1 Lidia Sanchez-Alcoholado,´ 2 Composition and Functionality Beatriz Mart´ın-Tejedor,1 Daniel Castellano-Castillo,2,3 Between Children With Type 1 Isabel Moreno-Indias,2,3 Antonio Urda-Cardona,1 Diabetes and MODY2 and Healthy Francisco J. Tinahones,2,3 Jose´ Carlos Fernandez-Garc´ ´ıa,2,3 and Control Subjects: A Case-Control Mar´ıa Isabel Queipo-Ortuno~ 2,3 Study Diabetes Care 2018;41:2385–2395 | https://doi.org/10.2337/dc18-0253 OBJECTIVE Type 1 diabetes is associated with compositional differences in gut microbiota. To date, no microbiome studies have been performed in maturity-onset diabetes of the young 2 (MODY2), a monogenic cause of diabetes. Gut microbiota of type 1 diabetes, MODY2, and healthy control subjects was compared. PATHOPHYSIOLOGY/COMPLICATIONS RESEARCH DESIGN AND METHODS This was a case-control study in 15 children with type 1 diabetes, 15 children with MODY2, and 13 healthy children. Metabolic control and potential factors mod- ifying gut microbiota were controlled. Microbiome composition was determined by 16S rRNA pyrosequencing. 1Pediatric Endocrinology, Hospital Materno- Infantil, Malaga,´ Spain RESULTS 2Clinical Management Unit of Endocrinology and Compared with healthy control subjects, type 1 diabetes was associated with a Nutrition, Laboratory of the Biomedical Research significantly lower microbiota diversity, a significantly higher relative abundance of Institute of Malaga,´ Virgen de la Victoria Uni- Bacteroides Ruminococcus Veillonella Blautia Streptococcus versityHospital,Universidad de Malaga,M´ alaga,´ , , , , and genera, and a Spain lower relative abundance of Bifidobacterium, Roseburia, Faecalibacterium, and 3Centro de Investigacion´ BiomedicaenRed(CIBER)´ Lachnospira. -
Food Allergy and Intolerance: a Narrative Review on Nutritional Concerns
nutrients Review Food Allergy and Intolerance: A Narrative Review on Nutritional Concerns Domenico Gargano 1,†, Ramapraba Appanna 2,†, Antonella Santonicola 2 , Fabio De Bartolomeis 1, Cristiana Stellato 2, Antonella Cianferoni 3, Vincenzo Casolaro 2 and Paola Iovino 2,* 1 Allergy and Clinical Immunology Unit, San Giuseppe Moscati Hospital, 83100 Avellino, Italy; [email protected] (D.G.); [email protected] (F.D.B.) 2 Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, 84081 Baronissi, Italy; [email protected] (R.A.); [email protected] (A.S.); [email protected] (C.S.); [email protected] (V.C.) 3 Division of Allergy and Immunology, The Children’s Hospital of Philadelphia, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA 19104, USA; [email protected] * Correspondence: [email protected]; Tel.: +39-335-7822672 † These authors contributed equally to this work. Abstract: Adverse food reactions include immune-mediated food allergies and non-immune-mediated intolerances. However, this distinction and the involvement of different pathogenetic mechanisms are often confused. Furthermore, there is a discrepancy between the perceived vs. actual prevalence of immune-mediated food allergies and non-immune reactions to food that are extremely common. The risk of an inappropriate approach to their correct identification can lead to inappropriate diets with severe nutritional deficiencies. This narrative review provides an outline of the pathophysiologic and clinical features of immune and non-immune adverse reactions to food—along with general Citation: Gargano, D.; Appanna, R.; diagnostic and therapeutic strategies. Special emphasis is placed on specific nutritional concerns for Santonicola, A.; De Bartolomeis, F.; each of these conditions from the combined point of view of gastroenterology and immunology, in Stellato, C.; Cianferoni, A.; Casolaro, an attempt to offer a useful tool to practicing physicians in discriminating these diverging disease V.; Iovino, P. -
Prolamin Degradation in Sourdoughs
Prolamin degradation in sourdoughs Jussi Loponen University of Helsinki EKT-sarja 1372 EKT series 1372 Helsinki 2006 Helsingin yliopisto Elintarviketeknologian laitos University of Helsinki Department of Food Technology EKT-SARJA 1372 EKT SERIES 1372 PROLAMIN DEGRADATION IN SOURDOUGHS JUSSI LOPONEN ACADEMIC DISSERTATION To be presented with the permission of the Faculty of Agriculture and Forestry of the University of Helsinki, for public criticism in the Walter-hall, Viikki on December 20th, 2006 at 12 o’clock noon. HELSINKI 2006 Custos Professor Hannu Salovaara Department of Food Technology University of Helsinki Helsinki, Finland Supervisors Professor Hannu Salovaara Department of Food Technology University of Helsinki Helsinki, Finland University Lecturer Tuula Sontag-Strohm Department of Food Technology University of Helsinki Helsinki, Finland Reviewers Dr. Berne Jones, Supervisory Research Chemist (retired) USDA, ARS, Cereal Crops Research Unit Madison, WI, USA Dr. Michael Gänzle, Assistant Professor Department of Agricultural, Food and Nutritional Science University of Alberta Edmonton, Canada Opponent Dr. Peter Weegels, Lead Technologist Unilever Research & Development Vlaardingen, the Netherlands ISBN 952-10-3581-1 (paperback) ISBN 952-10-3582-X (PDF) ISSN 0355-1180 Yliopistopaino Helsinki 2006 2 CONTENTS ABSTRACT 4 PREFACE 5 LIST OF ORIGINAL PUBLICATIONS AND AUTHORSHIPS 6 ABBREVIATIONS 7 1 INTRODUCTION 8 2 LITERATURE REVIEW 10 2.1 The Proteolytic systems of cereal grains 10 2.1.1 The Prolamins of the Triticeae cereals (wheat, -
Type-2 Diabetics Reduces Spatial Variation of Microbiome Based On
www.nature.com/scientificreports Corrected: Author Correction OPEN Type-2 Diabetics Reduces Spatial Variation of Microbiome Based on Extracellular Vesicles from Gut Microbes across Human Body Geumkyung Nah1, Sang-Cheol Park 2, Kangjin Kim2, Sungmin Kim3, Jaehyun Park 1, Sanghun Lee4* & Sungho Won 1,2,5* As a result of advances in sequencing technology, the role of gut microbiota in the mechanism of type-2 diabetes mellitus (T2DM) has been revealed. Studies showing wide distribution of microbiome throughout the human body, even in the blood, have motivated the investigation of the dynamics in gut microbiota across the humans. Particularly, extracellular vesicles (EVs), lipid bilayer structures secreted from the gut microbiota, have recently come into the spotlight because gut microbe-derived EVs afect glucose metabolism by inducing insulin resistance. Recently, intestine hyper-permeability linked to T2DM has also been associated with the interaction between gut microbes and leaky gut epithelium, which increases the uptake of macromolecules like lipopolysaccharide from the membranes of microbes leading to chronic infammation. In this article, we frstly investigate the co-occurrence of stool microbes and microbe-derived EVs across serum and urine in human subjects (N = 284), showing the dynamics and stability of gut derived EVs. Stool EVs are intermediate, while the bacterial composition in both urine and serum EVs is distinct from the stool microbiome. The co-occurrence of microbes was compared between patients with T2DM (N = 29) and matched in healthy subjects (N = 145). Our results showed signifcantly higher correlations in patients with T2DM compared to healthy subjects across stool, serum, and urine, which could be interpreted as the dysfunction of intestinal permeability in T2DM. -
Zonulin: a Biomarker and Regulator of Gastrointestinal Tight Gap Junctions RESOURCE GUIDE
Zonulin: A biomarker and regulator of gastrointestinal tight gap junctions RESOURCE GUIDE Science + Insight doctorsdata.com Zonulin: A biomarker and regulator of gastrointestinal tight gap junctions Research and clinical studies of the protein zonulin and the zonulin signaling pathway demonstrate the clinical efficacy of zonulin as a biomarker of intestinal permeability. Studies also confirm that zonulin signaling is an essential mechanism in promoting healthy immune function and tolerance at the gastrointestinal mucosal barrier. Disregulation of the zonulin signaling pathway disrupts normal gut barrier function and alters immune responses. As a result, high levels of serum zonulin may point to the presence of increased intestinal permeability. Over time, persistent high levels of zonulin in the blood may predispose susceptible individuals to inflammatory, autoimmune, and even neoplastic disorders by increasing the paracellular permeability of the gastrointestinal mucosa. As increased intestinal permeability persists only in the presence of high zonulin levels, the biomarker may also be used to monitor therapeutic interventions designed to restore gut barrier function. Zonulin is the only currently known reversible regulator of intestinal permeability. What is zonulin? The paracellular tight junctions between the intestinal epithelial cells are a critical component of the mucosal barrier and regulate the functional state of the paracellular pathway. Zonulin is a protein that regulates the reversible permeability of tight junctions. Zonulin is the endogenously produced analog of the Vibrio cholerae enterotoxin Zot. When Zot or zonulin bind to intestinal epithelial cells, a signal cascade is induced. The signal cascade disassembles the paracellular tight junctions between the epithelial cells of the intestinal mucosa, which increases intestinal permeability.